BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22614186)

  • 1. 131I SPECT/CT in the follow-up of patients with differentiated thyroid carcinoma.
    Menges M; Uder M; Kuwert T; Schmidt D
    Clin Nucl Med; 2012 Jun; 37(6):555-60. PubMed ID: 22614186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
    Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
    J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
    Wong KK; Sisson JC; Koral KF; Frey KA; Avram AM
    AJR Am J Roentgenol; 2010 Sep; 195(3):730-6. PubMed ID: 20729453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
    Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
    Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation.
    Schmidt D; Szikszai A; Linke R; Bautz W; Kuwert T
    J Nucl Med; 2009 Jan; 50(1):18-23. PubMed ID: 19091884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.
    Tharp K; Israel O; Hausmann J; Bettman L; Martin WH; Daitzchman M; Sandler MP; Delbeke D
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1435-42. PubMed ID: 15221294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
    Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
    AJR Am J Roentgenol; 2008 Dec; 191(6):1785-94. PubMed ID: 19020251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
    Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
    J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a
    Spanu A; Nuvoli S; Marongiu A; Gelo I; Mele L; Piras B; Madeddu G
    BMC Cancer; 2020 Mar; 20(1):239. PubMed ID: 32197595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification.
    Wakabayashi H; Nakajima K; Fukuoka M; Inaki A; Nakamura A; Kayano D; Kinuya S
    Ann Nucl Med; 2011 Nov; 25(9):609-15. PubMed ID: 21725630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data.
    Vural GU; Akkas BE; Ercakmak N; Basu S; Alavi A
    Clin Nucl Med; 2012 Oct; 37(10):953-9. PubMed ID: 22899202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of 131I SPECT/CT on the management of differentiated thyroid carcinoma outpatients with radioablation].
    Mizokami D; Kosuda S; Shiotani A; Kinoshita F; Saotome K; Morozumi K
    Nihon Jibiinkoka Gakkai Kaiho; 2014 May; 117(5):673-80. PubMed ID: 24956745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.
    Barwick T; Murray I; Megadmi H; Drake WM; Plowman PN; Akker SA; Chew SL; Grossman AB; Avril N
    Eur J Endocrinol; 2010 Jun; 162(6):1131-9. PubMed ID: 20212015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
    Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
    J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
    Ozkan E; Aras G; Kucuk NO
    Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of single-photon emission computed tomography/computed tomography in post-ablation
    Jiang L; Xiang Y; Huang R; Tian R; Liu B
    Pediatr Radiol; 2021 Aug; 51(9):1724-1731. PubMed ID: 33759024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer.
    Aide N; Heutte N; Rame JP; Rousseau E; Loiseau C; Henry-Amar M; Bardet S
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2075-84. PubMed ID: 19276233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
    Na SJ; Yoo IeR; O JH; Lin C; Lin Q; Kim SH; Chung SK
    Ann Nucl Med; 2012 Jan; 26(1):26-34. PubMed ID: 21971605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.